Dai Nippon Printing Co., Ltd. and CMIC HOLDINGS Co., Ltd. entered into a strategic alliance agreement that will focus on new needs in the extensive pharmaceutical value chain with the goal of creating new value in the medical and healthcare field.

The alliance aims to make new value proposals by bringing together CMIC’s pharmaceutical support functions and services with the advanced medical packaging, pharmaceutical synthesis, and secure information processing technologies offered by the DNP Group.

CMIC CMO Co., Ltd. has so far operated as a formulation development and manufacturing organization for the CMIC Group. As part of the new alliance, CMIC CMO will become a capital participation subsidiary of DNP.

In conjunction with the CMIC Group, the alliance will work on the integrated manufacture of active pharmaceutical ingredients (API) and the development of value-added pharmaceuticals.

As a result of the alliance, the resources of both partner companies will be combined to provide further enhanced support to pharmaceutical value chain. These include new value proposals related to the storage and distribution of pharmaceuticals, along with pre-symptomatic measures designed to reduce the risk of lifestyle-related diseases.

The two companies will collaborate and create synergies in the following business fields.

• Development of value-added pharmaceuticals by combining the packaging technology of the DNP Group with the drug formulation technology of the CMIC Group
• Establishment of an integrated system from the API process development and manufacturing of the DNP Group to the CMIC Group’s formulation development and manufacturing
• Collaboration in the CMIC Group’s clinical development and clinical trial site support business areas utilizing DNP Group technology and know how
• Business alliance targeting the building of a healthcare ecosystem

CMIC CMO will continue to provide comprehensive support for the development and manufacturing of pharmaceutical formulations, from investigational drugs to commercial applications.

According to the two companies, the new alliance will provide innovative services from a new perspective to meet the expectations of clients that entrust the development of formulations and pharmaceutical manufacture, leveraging the strengths of the DNP Group in P&I and the solid strengths of the CMIC Group developed since the company was established.